These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10349991)

  • 1. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature.
    Paal E; Thompson LD; Przygodzki RM; Bratthauer GL; Heffess CS
    Mod Pathol; 1999 May; 12(5):518-28. PubMed ID: 10349991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].
    Huo Z; Yang D; Chang XY; Wan JW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):670-5. PubMed ID: 19094485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of GNAS mutation in intraductal papillary mucinous neoplasm of the pancreas with concomitant pancreatic ductal adenocarcinoma.
    Ideno N; Ohtsuka T; Matsunaga T; Kimura H; Watanabe Y; Tamura K; Aso T; Aishima S; Miyasaka Y; Ohuchida K; Ueda J; Takahata S; Oda Y; Mizumoto K; Tanaka M
    Pancreas; 2015 Mar; 44(2):311-20. PubMed ID: 25479586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic analysis of 92 cases of pancreatic cystic neoplasm].
    Ji Y; Zhu XZ; Lou WH; Wang DQ; Jin DY; Zeng MS; Zeng HY
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):160-5. PubMed ID: 17535681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
    Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
    Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of incidental branch-duct intraductal papillary mucinous neoplasms of the pancreas: A study with magnetic resonance imaging cholangiopancreatography.
    Girometti R; Pravisani R; Intini SG; Isola M; Cereser L; Risaliti A; Zuiani C
    World J Gastroenterol; 2016 Nov; 22(43):9562-9570. PubMed ID: 27920477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.
    Thompson LD; Becker RC; Przygodzki RM; Adair CF; Heffess CS
    Am J Surg Pathol; 1999 Jan; 23(1):1-16. PubMed ID: 9888699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloid (mucinous noncystic) carcinoma of the pancreas.
    Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
    Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic tumors with cystic dilatation of the ducts: intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms.
    Adsay NV; Longnecker DS; Klimstra DS
    Semin Diagn Pathol; 2000 Feb; 17(1):16-30. PubMed ID: 10721804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
    Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
    Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal Papillary Mucinous Neoplasms Often Contain Epithelium From Multiple Subtypes and/or Are Unclassifiable.
    Schaberg KB; DiMaio MA; Longacre TA
    Am J Surg Pathol; 2016 Jan; 40(1):44-50. PubMed ID: 26469398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
    Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
    Oda Y; Aishima S; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y
    Hum Pathol; 2017 Jul; 65():71-78. PubMed ID: 28412205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas.
    Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW
    J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.